Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

7.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Cancer Therapies02:49

Cancer Therapies

10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

599
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
599
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

719
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
719

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A noninvasive urinary microRNA-based assay for the detection of pancreatic cancer from early to late stages: a case control study.

EClinicalMedicine·2025
Same author

Studies on the inhibition of methanogenesis and dechlorination by (4-hydroxyphenyl) chloromethanesulfonate.

Journal of pesticide science·2022
Same author

Laparoscopic approach as a safe and effective option for incarcerated femoral hernias.

Asian journal of endoscopic surgery·2021
Same author

Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23.

Journal of bone and mineral metabolism·2021
Same author

[Body weight and bone/calcium metabolism. Obesity and vitamin D.]

Clinical calcium·2018
Same author

Factors associated with inadequate responses to risedronate in Japanese patients with osteoporosis.

Journal of bone and mineral metabolism·2018

Related Experiment Video

Updated: Mar 8, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.9K

[Combination and sequential therapy using bisphosphonates.]

Ryo Okazaki1

  • 1Third Department of Medicine, Teikyo University Chiba Medical Center, Japan.

Clinical Calcium
|January 27, 2017
PubMed
Summary
This summary is machine-generated.

This review explores combining bisphosphonates with parathyroid hormone (PTH) and other osteoporosis drugs. It examines evidence for sequential and combination therapies to improve fracture prevention.

More Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.9K

Related Experiment Videos

Last Updated: Mar 8, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.9K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.9K

Area of Science:

  • Endocrinology and Bone Metabolism
  • Pharmacology of Osteoporosis Treatments

Background:

  • Osteoporosis management often requires combination therapy due to limitations of single agents.
  • Parathyroid hormone (PTH) has a limited duration of use, necessitating subsequent or preceding treatments.
  • Historically, combination therapies for osteoporosis, excluding vitamin D, were uncommon due to insufficient anti-fracture data.

Purpose of the Study:

  • To review the various sequential and combination strategies involving bisphosphonates and PTH for osteoporosis.
  • To assess the evolving landscape of osteoporosis treatment combinations.

Main Methods:

  • Literature review of studies investigating sequential and combination therapies for osteoporosis.
  • Focus on the interplay between bisphosphonates and parathyroid hormone (PTH).

Main Results:

  • Bisphosphonates have been investigated in diverse sequential and combination regimens with PTH.
  • Evidence for anti-fracture efficacy is crucial for the adoption of combination therapies.

Conclusions:

  • Sequential and combination therapies involving bisphosphonates and PTH are increasingly explored.
  • Further evidence on anti-fracture benefits will guide clinical practice in osteoporosis management.